Cost-Effectiveness of HLA-B*15:02 Screening in Malaysia

British Journal of Dermatology - United Kingdom
doi 10.1111/bjd.15832
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Association Between HLA-B*1502 Allele and Aromatic Antiepileptic Drugs-Induced Hypersensitivity Syndrome Reactions and the HLA-B*15:02 Pharmacogenetics Screening in Autistic Spectrum Disorder

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2014English

Cost-Effectiveness of Expanded Newborn Screening in Texas

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Cost Effectiveness of Colorectal Cancer Screening Strategies

Cancer Control
MedicineOncologyHematology
2015English

Association of HLA-B*41:02 With Henoch-Schönlein Purpura (IgA Vasculitis) in Spanish Individuals Irrespective of the HLA-DRB1 Status

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2015English

Personalised Breast Screening: Key Drivers of Cost Effectiveness

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

What Determines the Cost-Effectiveness of Diabetes Screening?

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2006English

Cost-Effectiveness of Carrier Screening for Cystic Fibrosis in Australia

Journal of Cystic Fibrosis
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2012English

Cost-Effectiveness Analysis of Annual Breast Cancer Screening in Japan.

Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening)
1997English

Cost Effectiveness in Screening for Down's Syndrome Still Unclear

BMJ
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy